Biocryst Pharmaceuticals Inc.’s(BCRX) MACD indicator has entered into bearish territory with a reading of -0.0317. The Zacks #4 Rank (“Sell”) stock fell nearly 2% to $8.00 in afternoon trade. The full-year Zacks Consensus Estimate is currently pegged at a loss of 78 cents per share, which has worsened by 5 cents over the past 2 months.
“BCRX” Free Stock Analysis: Buy? Sell? Hold?
Zacks Investment Research
Uncategorized